KZA 0.00% 8.0¢ kazia therapeutics limited

Across the pond...Nasdaq: KZIA, page-233

  1. 910 Posts.
    lightbulb Created with Sketch. 101
    "Entrectinib (INN),[2] sold under the brand name Rozlytrek, is an anti-cancer medication used to treat ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumors."

    https://en.wikipedia.org/wiki/Entrectinib
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.